nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—CYP3A7—Rifampicin—leprosy	0.0802	0.094	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.0802	0.094	CbGbCtD
Aprepitant—CYP3A7—Dapsone—leprosy	0.0662	0.0776	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0662	0.0776	CbGbCtD
Aprepitant—CYP3A5—Thalidomide—leprosy	0.0621	0.0728	CbGbCtD
Aprepitant—CYP3A5—Rifampicin—leprosy	0.0602	0.0705	CbGbCtD
Aprepitant—CYP2C19—Thalidomide—leprosy	0.0501	0.0588	CbGbCtD
Aprepitant—CYP3A5—Dapsone—leprosy	0.0497	0.0582	CbGbCtD
Aprepitant—CYP2C19—Rifampicin—leprosy	0.0485	0.0569	CbGbCtD
Aprepitant—CYP1A2—Thalidomide—leprosy	0.0462	0.0542	CbGbCtD
Aprepitant—CYP1A2—Rifampicin—leprosy	0.0448	0.0525	CbGbCtD
Aprepitant—CYP2C9—Thalidomide—leprosy	0.0417	0.0488	CbGbCtD
Aprepitant—CYP2C9—Rifampicin—leprosy	0.0403	0.0473	CbGbCtD
Aprepitant—CYP2C19—Dapsone—leprosy	0.0401	0.047	CbGbCtD
Aprepitant—CYP2C9—Dapsone—leprosy	0.0333	0.0391	CbGbCtD
Aprepitant—CYP3A4—Rifampicin—leprosy	0.0235	0.0275	CbGbCtD
Aprepitant—CYP3A4—Dapsone—leprosy	0.0194	0.0227	CbGbCtD
Aprepitant—TACR1—trigeminal nerve—leprosy	0.0162	0.34	CbGeAlD
Aprepitant—TACR1—cranial nerve—leprosy	0.0116	0.242	CbGeAlD
Aprepitant—TACR1—peripheral nervous system—leprosy	0.0076	0.159	CbGeAlD
Aprepitant—TACR1—nerve—leprosy	0.00592	0.124	CbGeAlD
Aprepitant—Peripheral sensory neuropathy—Thalidomide—leprosy	0.00352	0.0354	CcSEcCtD
Aprepitant—TACR3—nervous system—leprosy	0.00344	0.0721	CbGeAlD
Aprepitant—Septic shock—Thalidomide—leprosy	0.00333	0.0335	CcSEcCtD
Aprepitant—Proteinuria—Dapsone—leprosy	0.00223	0.0225	CcSEcCtD
Aprepitant—Protein urine present—Dapsone—leprosy	0.0022	0.0222	CcSEcCtD
Aprepitant—Altered state of consciousness—Thalidomide—leprosy	0.00218	0.0219	CcSEcCtD
Aprepitant—White blood cell count decreased—Thalidomide—leprosy	0.00202	0.0203	CcSEcCtD
Aprepitant—Inappropriate antidiuretic hormone secretion—Thalidomide—leprosy	0.00173	0.0174	CcSEcCtD
Aprepitant—Febrile neutropenia—Thalidomide—leprosy	0.00167	0.0168	CcSEcCtD
Aprepitant—Deep vein thrombosis—Thalidomide—leprosy	0.00165	0.0166	CcSEcCtD
Aprepitant—Serum creatinine increased—Thalidomide—leprosy	0.00163	0.0164	CcSEcCtD
Aprepitant—Oral candidiasis—Thalidomide—leprosy	0.00158	0.0159	CcSEcCtD
Aprepitant—Embolism—Thalidomide—leprosy	0.00157	0.0157	CcSEcCtD
Aprepitant—Seborrhoeic dermatitis—Thalidomide—leprosy	0.00147	0.0148	CcSEcCtD
Aprepitant—TACR1—testis—leprosy	0.00136	0.0284	CbGeAlD
Aprepitant—TACR1—nervous system—leprosy	0.00133	0.0279	CbGeAlD
Aprepitant—Muscular weakness—Dapsone—leprosy	0.00126	0.0126	CcSEcCtD
Aprepitant—Proteinuria—Thalidomide—leprosy	0.00114	0.0115	CcSEcCtD
Aprepitant—Protein urine present—Thalidomide—leprosy	0.00113	0.0113	CcSEcCtD
Aprepitant—Photosensitivity reaction—Dapsone—leprosy	0.00112	0.0113	CcSEcCtD
Aprepitant—Herpes simplex—Thalidomide—leprosy	0.00109	0.011	CcSEcCtD
Aprepitant—Neuropathy peripheral—Dapsone—leprosy	0.00108	0.0108	CcSEcCtD
Aprepitant—Gait disturbance—Thalidomide—leprosy	0.00103	0.0104	CcSEcCtD
Aprepitant—Phosphatase alkaline increased—Thalidomide—leprosy	0.00101	0.0101	CcSEcCtD
Aprepitant—Pulmonary embolism—Thalidomide—leprosy	0.00101	0.0101	CcSEcCtD
Aprepitant—Eructation—Thalidomide—leprosy	0.000987	0.00993	CcSEcCtD
Aprepitant—Pharyngitis—Dapsone—leprosy	0.000978	0.00984	CcSEcCtD
Aprepitant—Depressed level of consciousness—Thalidomide—leprosy	0.00097	0.00976	CcSEcCtD
Aprepitant—Candida infection—Thalidomide—leprosy	0.00096	0.00965	CcSEcCtD
Aprepitant—Blood urea increased—Thalidomide—leprosy	0.000949	0.00954	CcSEcCtD
Aprepitant—Tinnitus—Dapsone—leprosy	0.000919	0.00925	CcSEcCtD
Aprepitant—Euphoric mood—Thalidomide—leprosy	0.000864	0.00869	CcSEcCtD
Aprepitant—Erythema—Dapsone—leprosy	0.000858	0.00863	CcSEcCtD
Aprepitant—Thrombophlebitis—Thalidomide—leprosy	0.000843	0.00848	CcSEcCtD
Aprepitant—Diabetes mellitus—Thalidomide—leprosy	0.000839	0.00844	CcSEcCtD
Aprepitant—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000839	0.00844	CcSEcCtD
Aprepitant—Photosensitivity—Thalidomide—leprosy	0.000831	0.00836	CcSEcCtD
Aprepitant—Cough—Dapsone—leprosy	0.000749	0.00753	CcSEcCtD
Aprepitant—Lethargy—Thalidomide—leprosy	0.000744	0.00749	CcSEcCtD
Aprepitant—Hyponatraemia—Thalidomide—leprosy	0.000732	0.00737	CcSEcCtD
Aprepitant—Osteoarthritis—Thalidomide—leprosy	0.00073	0.00734	CcSEcCtD
Aprepitant—Tachycardia—Dapsone—leprosy	0.000684	0.00688	CcSEcCtD
Aprepitant—Blood creatinine increased—Thalidomide—leprosy	0.000683	0.00687	CcSEcCtD
Aprepitant—Dehydration—Thalidomide—leprosy	0.000678	0.00682	CcSEcCtD
Aprepitant—Hypokalaemia—Thalidomide—leprosy	0.000664	0.00668	CcSEcCtD
Aprepitant—Breast disorder—Thalidomide—leprosy	0.000659	0.00663	CcSEcCtD
Aprepitant—Cramp muscle—Thalidomide—leprosy	0.000657	0.00661	CcSEcCtD
Aprepitant—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000657	0.00661	CcSEcCtD
Aprepitant—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000657	0.00661	CcSEcCtD
Aprepitant—Alanine aminotransferase increased—Thalidomide—leprosy	0.000643	0.00647	CcSEcCtD
Aprepitant—Muscular weakness—Thalidomide—leprosy	0.000643	0.00647	CcSEcCtD
Aprepitant—Abdominal distension—Thalidomide—leprosy	0.000635	0.00639	CcSEcCtD
Aprepitant—Insomnia—Dapsone—leprosy	0.000634	0.00637	CcSEcCtD
Aprepitant—Dysphagia—Thalidomide—leprosy	0.000631	0.00634	CcSEcCtD
Aprepitant—Neutropenia—Thalidomide—leprosy	0.00059	0.00593	CcSEcCtD
Aprepitant—Upper respiratory tract infection—Thalidomide—leprosy	0.000586	0.00589	CcSEcCtD
Aprepitant—Pollakiuria—Thalidomide—leprosy	0.000582	0.00586	CcSEcCtD
Aprepitant—Photosensitivity reaction—Thalidomide—leprosy	0.000576	0.00579	CcSEcCtD
Aprepitant—Weight increased—Thalidomide—leprosy	0.000574	0.00577	CcSEcCtD
Aprepitant—Gastrointestinal pain—Dapsone—leprosy	0.000573	0.00576	CcSEcCtD
Aprepitant—Weight decreased—Thalidomide—leprosy	0.00057	0.00574	CcSEcCtD
Aprepitant—Hyperglycaemia—Thalidomide—leprosy	0.000569	0.00572	CcSEcCtD
Aprepitant—Pneumonia—Thalidomide—leprosy	0.000565	0.00569	CcSEcCtD
Aprepitant—Infestation NOS—Thalidomide—leprosy	0.000562	0.00566	CcSEcCtD
Aprepitant—Infestation—Thalidomide—leprosy	0.000562	0.00566	CcSEcCtD
Aprepitant—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000557	0.00561	CcSEcCtD
Aprepitant—Acute coronary syndrome—Thalidomide—leprosy	0.000554	0.00557	CcSEcCtD
Aprepitant—Body temperature increased—Dapsone—leprosy	0.000554	0.00557	CcSEcCtD
Aprepitant—Abdominal pain—Dapsone—leprosy	0.000554	0.00557	CcSEcCtD
Aprepitant—Renal failure—Thalidomide—leprosy	0.000553	0.00556	CcSEcCtD
Aprepitant—Myocardial infarction—Thalidomide—leprosy	0.000551	0.00554	CcSEcCtD
Aprepitant—Neuropathy peripheral—Thalidomide—leprosy	0.000551	0.00554	CcSEcCtD
Aprepitant—Stomatitis—Thalidomide—leprosy	0.000548	0.00551	CcSEcCtD
Aprepitant—Conjunctivitis—Thalidomide—leprosy	0.000546	0.0055	CcSEcCtD
Aprepitant—Haematuria—Thalidomide—leprosy	0.000536	0.00539	CcSEcCtD
Aprepitant—Bradycardia—Thalidomide—leprosy	0.000514	0.00517	CcSEcCtD
Aprepitant—Hypoaesthesia—Thalidomide—leprosy	0.000502	0.00505	CcSEcCtD
Aprepitant—Pharyngitis—Thalidomide—leprosy	0.000501	0.00504	CcSEcCtD
Aprepitant—Urinary tract disorder—Thalidomide—leprosy	0.000498	0.00501	CcSEcCtD
Aprepitant—Urethral disorder—Thalidomide—leprosy	0.000495	0.00498	CcSEcCtD
Aprepitant—Erythema multiforme—Thalidomide—leprosy	0.000477	0.0048	CcSEcCtD
Aprepitant—Eye disorder—Thalidomide—leprosy	0.000472	0.00474	CcSEcCtD
Aprepitant—Tinnitus—Thalidomide—leprosy	0.000471	0.00473	CcSEcCtD
Aprepitant—Cardiac disorder—Thalidomide—leprosy	0.000468	0.00471	CcSEcCtD
Aprepitant—Angiopathy—Thalidomide—leprosy	0.000458	0.00461	CcSEcCtD
Aprepitant—Immune system disorder—Thalidomide—leprosy	0.000456	0.00459	CcSEcCtD
Aprepitant—Mediastinal disorder—Thalidomide—leprosy	0.000455	0.00458	CcSEcCtD
Aprepitant—Chills—Thalidomide—leprosy	0.000453	0.00456	CcSEcCtD
Aprepitant—Alopecia—Thalidomide—leprosy	0.000446	0.00449	CcSEcCtD
Aprepitant—Vomiting—Dapsone—leprosy	0.000445	0.00448	CcSEcCtD
Aprepitant—Mental disorder—Thalidomide—leprosy	0.000442	0.00445	CcSEcCtD
Aprepitant—Malnutrition—Thalidomide—leprosy	0.000439	0.00442	CcSEcCtD
Aprepitant—Headache—Dapsone—leprosy	0.000439	0.00441	CcSEcCtD
Aprepitant—Flatulence—Thalidomide—leprosy	0.000433	0.00435	CcSEcCtD
Aprepitant—Dysgeusia—Thalidomide—leprosy	0.00043	0.00433	CcSEcCtD
Aprepitant—Back pain—Thalidomide—leprosy	0.000425	0.00427	CcSEcCtD
Aprepitant—Muscle spasms—Thalidomide—leprosy	0.000422	0.00425	CcSEcCtD
Aprepitant—Nausea—Dapsone—leprosy	0.000416	0.00419	CcSEcCtD
Aprepitant—Tremor—Thalidomide—leprosy	0.000412	0.00414	CcSEcCtD
Aprepitant—Ill-defined disorder—Thalidomide—leprosy	0.000408	0.0041	CcSEcCtD
Aprepitant—Anaemia—Thalidomide—leprosy	0.000406	0.00408	CcSEcCtD
Aprepitant—Angioedema—Thalidomide—leprosy	0.000401	0.00404	CcSEcCtD
Aprepitant—Malaise—Thalidomide—leprosy	0.000396	0.00399	CcSEcCtD
Aprepitant—Syncope—Thalidomide—leprosy	0.000394	0.00396	CcSEcCtD
Aprepitant—Palpitations—Thalidomide—leprosy	0.000388	0.00391	CcSEcCtD
Aprepitant—Loss of consciousness—Thalidomide—leprosy	0.000386	0.00388	CcSEcCtD
Aprepitant—Cough—Thalidomide—leprosy	0.000383	0.00386	CcSEcCtD
Aprepitant—Convulsion—Thalidomide—leprosy	0.000381	0.00383	CcSEcCtD
Aprepitant—Hypertension—Thalidomide—leprosy	0.000379	0.00382	CcSEcCtD
Aprepitant—Chest pain—Thalidomide—leprosy	0.000374	0.00376	CcSEcCtD
Aprepitant—Myalgia—Thalidomide—leprosy	0.000374	0.00376	CcSEcCtD
Aprepitant—Arthralgia—Thalidomide—leprosy	0.000374	0.00376	CcSEcCtD
Aprepitant—Anxiety—Thalidomide—leprosy	0.000373	0.00375	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000371	0.00374	CcSEcCtD
Aprepitant—Discomfort—Thalidomide—leprosy	0.00037	0.00372	CcSEcCtD
Aprepitant—Dry mouth—Thalidomide—leprosy	0.000366	0.00368	CcSEcCtD
Aprepitant—Confusional state—Thalidomide—leprosy	0.000362	0.00364	CcSEcCtD
Aprepitant—Oedema—Thalidomide—leprosy	0.000359	0.00361	CcSEcCtD
Aprepitant—Infection—Thalidomide—leprosy	0.000356	0.00358	CcSEcCtD
Aprepitant—Shock—Thalidomide—leprosy	0.000353	0.00355	CcSEcCtD
Aprepitant—Nervous system disorder—Thalidomide—leprosy	0.000352	0.00354	CcSEcCtD
Aprepitant—Thrombocytopenia—Thalidomide—leprosy	0.000351	0.00353	CcSEcCtD
Aprepitant—Tachycardia—Thalidomide—leprosy	0.00035	0.00352	CcSEcCtD
Aprepitant—Skin disorder—Thalidomide—leprosy	0.000348	0.0035	CcSEcCtD
Aprepitant—Hyperhidrosis—Thalidomide—leprosy	0.000347	0.00349	CcSEcCtD
Aprepitant—Anorexia—Thalidomide—leprosy	0.000342	0.00344	CcSEcCtD
Aprepitant—Hypotension—Thalidomide—leprosy	0.000335	0.00337	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Thalidomide—leprosy	0.000327	0.00329	CcSEcCtD
Aprepitant—Insomnia—Thalidomide—leprosy	0.000324	0.00326	CcSEcCtD
Aprepitant—Paraesthesia—Thalidomide—leprosy	0.000322	0.00324	CcSEcCtD
Aprepitant—Dyspnoea—Thalidomide—leprosy	0.00032	0.00322	CcSEcCtD
Aprepitant—Somnolence—Thalidomide—leprosy	0.000319	0.00321	CcSEcCtD
Aprepitant—Dyspepsia—Thalidomide—leprosy	0.000316	0.00317	CcSEcCtD
Aprepitant—Decreased appetite—Thalidomide—leprosy	0.000312	0.00314	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Thalidomide—leprosy	0.00031	0.00311	CcSEcCtD
Aprepitant—Fatigue—Thalidomide—leprosy	0.000309	0.00311	CcSEcCtD
Aprepitant—Constipation—Thalidomide—leprosy	0.000307	0.00308	CcSEcCtD
Aprepitant—Pain—Thalidomide—leprosy	0.000307	0.00308	CcSEcCtD
Aprepitant—CYP3A4—nervous system—leprosy	0.000301	0.0063	CbGeAlD
Aprepitant—Feeling abnormal—Thalidomide—leprosy	0.000295	0.00297	CcSEcCtD
Aprepitant—Gastrointestinal pain—Thalidomide—leprosy	0.000293	0.00295	CcSEcCtD
Aprepitant—Urticaria—Thalidomide—leprosy	0.000285	0.00287	CcSEcCtD
Aprepitant—Abdominal pain—Thalidomide—leprosy	0.000283	0.00285	CcSEcCtD
Aprepitant—Body temperature increased—Thalidomide—leprosy	0.000283	0.00285	CcSEcCtD
Aprepitant—Hypersensitivity—Thalidomide—leprosy	0.000264	0.00266	CcSEcCtD
Aprepitant—Asthenia—Thalidomide—leprosy	0.000257	0.00259	CcSEcCtD
Aprepitant—Pruritus—Thalidomide—leprosy	0.000254	0.00255	CcSEcCtD
Aprepitant—Diarrhoea—Thalidomide—leprosy	0.000245	0.00247	CcSEcCtD
Aprepitant—Dizziness—Thalidomide—leprosy	0.000237	0.00239	CcSEcCtD
Aprepitant—Vomiting—Thalidomide—leprosy	0.000228	0.00229	CcSEcCtD
Aprepitant—Rash—Thalidomide—leprosy	0.000226	0.00227	CcSEcCtD
Aprepitant—Dermatitis—Thalidomide—leprosy	0.000226	0.00227	CcSEcCtD
Aprepitant—Headache—Thalidomide—leprosy	0.000225	0.00226	CcSEcCtD
Aprepitant—Nausea—Thalidomide—leprosy	0.000213	0.00214	CcSEcCtD
